Escitalopram Oxalate Tablet, Film Coated
Product Images NDC 68645-520

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Escitalopram Oxalate (NDC 68645-520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Legacy Pharmaceutical Packaging, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Escitalopram 10mg

Escitalopram 10mg
This is a medication called Escitalopram, which comes in the form of a tablet with a strength of 10mg. The package includes 30 tablets and should be stored in a tight container as described in the USP. The usual dosage information can be found on the package insert. It is Rx only and the Medication Guide should be dispensed separately to each patient. It was manufactured and distributed by Cipla USA Inc. and packaged by Legacy Pharmaceutical Packaging LLG, Earth City, MO 63045.*
FDA Label Image

Escitalopram 20mg

Escitalopram 20mg
This is the description: This is a medication packaged in a bottle with 30 tablets by Legacy Pharmaceutical Packaging LLC. The medication is called Escitalopram and it's only available with a prescription. The tablets should be stored in a tightly sealed container as per the USP guidelines. The recommended dosage is mentioned in the package insert. The medication is manufactured for Cipla USA Inc., and it comes with a medication guide that should be given to each patient separately by the pharmacist.*
FDA Label Image

Image (Escitalopram Tabs Cipla Bottle 1)

Image (Escitalopram Tabs   Cipla Bottle 1)
The text provides information about a tablet medication's effects on suicidal tendencies. The table shows different age ranges and the drug's impact compared to a placebo on the number of suicidal cases per 1000 patients treated. The medication resulted in additional cases for patients under 18 and 828 total cases. For patients over 65, the number of suicidal cases was lower compared to the placebo.*
FDA Label Image

Image (Escitalopram Tabs Cipla Bottle 2)

Image (Escitalopram Tabs   Cipla Bottle 2)
This is a TABLE2 that shows the Treatment-Emergent Adverse Reactions observed with a frequency of greater than 2% and higher than placebo for Major Depressive Disorder. It compares the adverse reactions between Escitalopram and Placebo where N=715. It shows the percentage of patients experiencing the reactions divided into categories such as Autonomic Nervous System Disorders, Central and Peripheral Nervous System Disorders, Gastrointestinal Disorders, General, Psychiatric Disorders, Respiratory System Disorders, and Urogenital. It also shows the denominator used for males only and females only for some of the reactions. Some of the common reactions that were observed in Escitalopram were Dry Mouth, Sweating Increased, Dizziness, Nausea, Diarrhea, Influenza-Tike Symptoms, Fatigue, Insomnia, Somnolence, Rhinitis, and Ejaculation Disorder.*
FDA Label Image

Image (Escitalopram Tabs Cipla Bottle 3)

Image (Escitalopram Tabs   Cipla Bottle 3)
The given text provides a table of Treatment-Emergent Adverse Reactions observed with a frequency of greater than 2% for patients suffering from Generalized Anxiety Disorder. The table compares the percentage of adverse reactions between the group treated with Escitalopram and the group administered placebo. The adverse reactions are categorized into various systems such as Autonomic Nervous System Disorders, Central and Peripheral Nervous System Disorders, Gastrolntestinal Disorders, and more. The adverse reactions include Dry Mouth, Headache, Nausea, Insomnia, and others. The text also mentions the sample size for males and females separately.*
FDA Label Image

Image (Escitalopram Tabs Cipla Bottle 4)

Image (Escitalopram Tabs   Cipla Bottle 4)
The text presents a table showing the incidence of common adverse reactions in patients with Major Depressive Disorder, comparing a placebo group and two groups taking Escitalopram at different dosages. Adverse reactions include Insomnia, Diarrhea, Dry Mouth, Somnolence, Dizziness, Sweating Increased, Constipation, Fatigue, and Indigestion. The percentage of patients experiencing each adverse reaction is provided for each group.*
FDA Label Image

Image (Escitalopram Tabs Cipla Bottle 5)

Image (Escitalopram Tabs   Cipla Bottle 5)
This text describes a table showing the incidence of sexual side effects in placebo-controlled clinical trials for a medication called Escitalopram. The table includes the adverse events and the percentage of people who experienced them for both those who took the medication and those who took a placebo. The adverse events listed include ejaculation disorder, ejaculatory delay, decreased libido, impotence and anorgasmia. There is also a breakdown of the results by gender, with decreased libido being reported by both males and females, whereas the other adverse events were reported by males only.*
FDA Label Image

Image (Escitalopram Tabs Cipla Bottle 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.